Jump to content
RemedySpot.com

Re: Copaxone and LDN

Rate this topic


Guest guest

Recommended Posts

Guest guest

HI ARLENE-

I TAKE COPAXONE AND LDN. I'VE QUIT COPAXONE AND RESTARTED -

WITH NO ILL-EFFECTS. I TAKE COPAXONE BECAUSE RESEARCH DOES

SHOW REDUCTION OF EXACERBATIONS WITH THE " CRAB " DRUGS. I

KNOW I'LL GET NEGATIVE FEEDBACK - BUT THE TRUTH IS - WHY NOT

DO EVERYTHING POSSIBLE TO IMPROVE SYMPTOMS AND LESSEN THE

IMPACT MS HAS ON OUR BODIES AND LIVES.

TOM, I STARTED TAKING BENFOTIAMINE - I SLEPT 8 HOURS LAST

NIGHT. I'M SO GRATEFUL FOR YOUR GENEROUSITY OF INFORMATION

AND EXPERIENCE.

BESTAUNT

Link to comment
Share on other sites

Guest guest

YASH-

WHY DISCONTINUE COPAXONE? I JUST DON'T GET THE LOGIC,

UNLESS SOMEONE IS NEEDLE PHOBIC OR MOTIVATION IS PROMPTED BY

FINANCIAL CONCERNS. MAYBE I PUT TOO MUCH FAITH IN

TRADITIONAL MEDICINE.

BESTAUNT

Link to comment
Share on other sites

Guest guest

Bestaunt:

Hi!, you are absolutely right!. The person I was responding

to wanted to stop copaxone in favor of LDN, since there was

progression in presence of copa. My preference is to add LDN to

copa. In this way, one is doing everything possible to prevent

progression. Relying on LDN alone is risky, but it apparently works

for some.

Yash

> YASH-

> WHY DISCONTINUE COPAXONE? I JUST DON'T GET THE LOGIC,

> UNLESS SOMEONE IS NEEDLE PHOBIC OR MOTIVATION IS PROMPTED BY

> FINANCIAL CONCERNS. MAYBE I PUT TOO MUCH FAITH IN

> TRADITIONAL MEDICINE.

> BESTAUNT

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...